Testing effectiveness (Phase 2)Ended earlyNCT03520712
What this trial is testing
Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5
Who this might be right for
Hemophilia AGene TherapyClotting Disorders+1 more
BioMarin Pharmaceutical 3